Skip to content
Brand AI

Liminal BioSciences

Recent events

Recent events tied to this brand in public sources.

Back to profile4 entries

  1. 2022

    Liminal BioSciences appoints Nicole Rusaw interim CFO

    Liminal BioSciences announced the appointment of Nicole Rusaw as interim Chief Financial Officer, effective March 2, 2022.

    Source

  2. 2021

    Liminal BioSciences closes sale of plasma-derived therapeutics manufacturing subsidiary

    Liminal BioSciences announced that it had closed the divestment of its plasma-derived therapeutics manufacturing subsidiary to Kedrion. The sale consideration for Prometic Bioproduction was USD 5 million, subject to adjustments.

    Source

  3. 2021

    Liminal BioSciences announces plasma business divestment agreement with Kedrion

    Liminal BioSciences reported that it had entered into a definitive share purchase agreement for the divestment of its plasma collection centers and an option agreement for the divestment of its Ryplazim-related assets with Kedrion. The proposed transaction was not reported as completed.

    Source

  4. 2021

    Liminal BioSciences reported fourth-quarter and 2020 results

    Liminal BioSciences reported financial results for the fourth quarter and year ended December 31, 2020.

    Source